Following a national announcement, the weight loss medication tirzepatide (Mounjaro®) is set to become available for patients in mid and south Essex.
Initially, this medication will only be accessible through specialist Tier 3 weight management services, not directly from your GP. Access will be prioritised for individuals with the most significant health risks, based on strict clinical criteria including a high BMI and multiple other health conditions.